Sectors ETFs Today Universe Correlation Playbook Watchlists Portfolios News Alerts Research Bots About

Daily digest

One email a day · alerts + bubble shifts · free during beta.

About Alerts Research Support ♡Disclosures Terms Privacy FR PT API Follow on X

US equities · Daily close · Refreshed nightly 22:30 Paris

Not investment advice. QuantAbundancia is educational research only. Nothing on this site is a recommendation to buy, sell, or hold any security. Past performance does not guarantee future results. Full disclosures.

We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.

News

High-signal headlines only — macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

3,446 signal articles · 313 in last 24h · 15,006 total before filter · latest 53m ago

313last 24h

1804last 7d

320🟢 bullish (7d)

187🔴 bearish (7d)

129publishers

All 🌍 Macro260 📊 Earnings917 🤝 M&A78 ⚖️ Regulatory20 🚀 Product14 📈 Analyst20

✕ clear all filtersticker: ABTsentiment: neutralSentiment:bullish neutral bearish show all (incl. clickbait)

MarketBeat4d agoneutral

Tandem Diabetes Care Q1 Earnings Call Highlights

Tandem Diabetes Care (NASDAQ:TNDM) reported record first-quarter pump shipments and sales for 2026, while reaffirming its full-year outlook as the diabetes technology company advances a shift toward pharmacy-channel reimbursement, expands direct international operations and prepares several product

ABT